FSD Pharma Inc - Class B - Class B (Sub Voting)

Research FSD Pharma Inc - Class B - Class B (Sub Voting) (QNTM) on Bullrun: market cap USD 24.85M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 24.85M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0-USD 26.18M-USD 8.24Mn/a-16.21USD 1.91MUSD 1.88MUSD 6.92M
FY2024USD 0-USD 14.20M-USD 6.88Mn/a-26.12USD 6.00MUSD 824.92KUSD 11.48M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 24.85Mn/an/an/a
20252025-12-31USD 28.38Mn/an/an/a
20242024-12-31USD 8.46Mn/an/an/a
20232023-12-29USD 36.23Mn/an/an/a
20222022-12-30USD 30.03Mn/an/an/a
20212021-12-31USD 41.26Mn/an/an/a

About FSD Pharma Inc - Class B - Class B (Sub Voting)

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is FSD Pharma Inc - Class B - Class B (Sub Voting)'s market cap?

FSD Pharma Inc - Class B - Class B (Sub Voting)'s market capitalization is USD 24.85M.

What does FSD Pharma Inc - Class B - Class B (Sub Voting) do?

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.